Development and validation of DNA microarray for genotyping group A rotavirus VP4 (P[4], P[6], P[8], P[9], and P[14]) and VP7 (G1 to G6, G8 to G10, and G12) genes.

PubWeight™: 0.87‹?›

🔗 View Article (PMC 1951270)

Published in J Clin Microbiol on June 13, 2007

Authors

Shinjiro Honma1, Vladimir Chizhikov, Norma Santos, Masatoshi Tatsumi, Maria do Carmo S T Timenetsky, Alexandre C Linhares, Joana D'Arc P Mascarenhas, Hiroshi Ushijima, George E Armah, Jon R Gentsch, Yasutaka Hoshino

Author Affiliations

1: Epidemiology Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-8026, USA.

Articles cited by this

Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol (1990) 10.23

Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol (1992) 8.25

Rotavirus and severe childhood diarrhea. Emerg Infect Dis (2006) 7.80

Microarray-based detection and genotyping of viral pathogens. Proc Natl Acad Sci U S A (2002) 7.27

Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity. Proc Natl Acad Sci U S A (1985) 5.94

Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirus. J Virol (1983) 5.44

Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol (2004) 5.20

Definition of human rotavirus serotypes by plaque reduction assay. Infect Immun (1982) 5.19

Direct serotyping of human rotavirus in stools by an enzyme-linked immunosorbent assay using serotype 1-, 2-, 3-, and 4-specific monoclonal antibodies to VP7. J Infect Dis (1987) 4.64

Identification of the two rotavirus genes determining neutralization specificities. J Virol (1986) 4.35

Simple and specific enzyme immunoassay using monoclonal antibodies for serotyping human rotaviruses. J Clin Microbiol (1987) 3.54

Characterization of rotavirus strains from newborns in New Delhi, India. J Clin Microbiol (1994) 3.50

DNA chips: state-of-the art. Nat Biotechnol (1998) 3.31

Specific enzyme-linked immunoassay for rotavirus serotypes 1 and 3. J Clin Microbiol (1985) 3.23

Review of G and P typing results from a global collection of rotavirus strains: implications for vaccine development. J Infect Dis (1996) 3.20

Rotavirus genotyping: keeping up with an evolving population of human rotaviruses. J Clin Virol (2004) 3.02

Rotavirus vaccines: current prospects and future challenges. Lancet (2006) 2.97

Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis (2005) 2.82

Typing and subtyping influenza virus using DNA microarrays and multiplex reverse transcriptase PCR. J Clin Microbiol (2001) 2.69

Evolutionary history and global spread of the emerging g12 human rotaviruses. J Virol (2006) 2.12

Detection and genotyping of human group A rotaviruses by oligonucleotide microarray hybridization. J Clin Microbiol (2002) 2.12

Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries. Vaccine (1999) 2.07

Chips with everything: DNA microarrays in infectious diseases. Lancet Infect Dis (2004) 1.87

Medical applications of microarray technologies: a regulatory science perspective. Nat Genet (2002) 1.67

Diversity within the VP4 gene of rotavirus P[8] strains: implications for reverse transcription-PCR genotyping. J Clin Microbiol (2000) 1.63

Identification of human and bovine rotavirus serotypes by polymerase chain reaction. Epidemiol Infect (1992) 1.62

Rapid serotyping of human rotavirus strains by solid-phase immune electron microscopy. J Clin Microbiol (1984) 1.60

Rotavirus serotypes: classification and importance in epidemiology, immunity, and vaccine development. J Health Popul Nutr (2000) 1.53

The role of serum antibodies in the protection against rotavirus disease: an overview. Clin Infect Dis (2002) 1.53

Characterization of a novel P[25],G11 human group a rotavirus. J Clin Microbiol (2005) 1.46

Identification of a novel VP4 genotype carried by a serotype G5 porcine rotavirus strain. Virology (2005) 1.42

Nigerian rotavirus serotype G8 could not be typed by PCR due to nucleotide mutation at the 3' end of the primer binding site. Arch Virol (1997) 1.40

Microarray analysis of evolution of RNA viruses: evidence of circulation of virulent highly divergent vaccine-derived polioviruses. Proc Natl Acad Sci U S A (2003) 1.33

Use of oligonucleotide microarrays for rapid detection and serotyping of acute respiratory disease-associated adenoviruses. J Clin Microbiol (2004) 1.32

Rotavirus strains bearing genotype G9 or P[9] recovered from Brazilian children with diarrhea from 1997 to 1999. J Clin Microbiol (2001) 1.25

The relative frequencies of G serotypes of rotaviruses recovered from hospitalized children with diarrhea: A 10-year survey (1987-1996) in Japan with a review of globally collected data. Microbiol Immunol (2000) 1.16

Relative frequency of VP4 gene alleles among human rotaviruses recovered over a 10-year period (1982-1991) from Japanese children with diarrhea. J Clin Microbiol (1993) 1.16

New mosaic subgenotype of varicella-zoster virus in the USA: VZV detection and genotyping by oligonucleotide-microarray. J Virol Methods (2006) 1.11

Molecular characterization of a new porcine rotavirus P genotype found in an asymptomatic pig in Slovenia. Virology (2006) 1.10

Identification of group A porcine rotavirus strains bearing a novel VP4 (P) Genotype in Italian swine herds. J Clin Microbiol (2006) 1.07

Characterization of incompletely typed rotavirus strains from Guinea-Bissau: identification of G8 and G9 types and a high frequency of mixed infections. Virology (2003) 1.03

Retracted Diversity in Indian equine rotaviruses: identification of genotype G10,P6[1] and G1 strains and a new VP7 genotype (G16) strain in specimens from diarrheic foals in India. J Clin Microbiol (2006) 1.02

Gene expression microarrays: a 21st century tool for directed vaccine design. Vaccine (2001) 0.97

Rotavirus vaccines: success by reassortment? Science (1994) 0.97

Genital human papillomavirus genotyping by HPV oligonucleotide microarray in Korean commercial sex workers. J Med Virol (2003) 0.96

Sequence diversity of Jeryl Lynn strain of mumps virus: quantitative mutant analysis for vaccine quality control. Virology (2002) 0.96

Typing of human rotaviruses: nucleotide mismatches between the VP7 gene and primer are associated with genotyping failure. Virol J (2005) 0.95

Microarrays for genotyping human group a rotavirus by multiplex capture and type-specific primer extension. J Clin Microbiol (2003) 0.93

DNA microarray technique for detection and identification of seven flaviviruses pathogenic for man. J Med Virol (2005) 0.91

Detection of hepatitis B virus DNA in sera from patients with chronic hepatitis B virus infection by DNA microarray method. J Clin Microbiol (2003) 0.91

Microarray technology for identification and distinction of hantaviruses. J Med Virol (2004) 0.90

Dominating prevalence of P[8],G1 and P[8],G9 rotavirus strains among children admitted to hospital between 2000 and 2003 in Budapest, Hungary. J Med Virol (2005) 0.90

Nucleotide variation in the VP7 gene affects PCR genotyping of G9 rotaviruses identified in Italy. J Med Virol (2004) 0.89

Genotyping of measles virus in clinical specimens on the basis of oligonucleotide microarray hybridization patterns. J Clin Microbiol (2006) 0.89

VP7 gene polymorphism of serotype G9 rotavirus strains and its impact on G genotype determination by PCR. Virus Res (2003) 0.86

Rotavirus typing methods and algorithms. Rev Med Virol (2004) 0.85

Microarray assay for detection and discrimination of Orthopoxvirus species. J Med Virol (2006) 0.85

Nucleotide mismatches between the VP7 gene and the primer are associated with genotyping failure of a specific lineage from G1 rotavirus strains. Virol J (2006) 0.81

Articles by these authors

Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med (2006) 9.93

Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol (2004) 5.20

Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol (2011) 3.87

The complete genomic sequence of Nocardia farcinica IFM 10152. Proc Natl Acad Sci U S A (2004) 3.01

Rotavirus vaccines: current prospects and future challenges. Lancet (2006) 2.97

Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments. Arch Virol (2008) 2.77

Genetic diversity of norovirus and sapovirus in hospitalized infants with sporadic cases of acute gastroenteritis in Chiang Mai, Thailand. J Clin Microbiol (2004) 2.53

Isolation and molecular characterization of Aichi viruses from fecal specimens collected in Japan, Bangladesh, Thailand, and Vietnam. J Clin Microbiol (2007) 2.45

Oral rotavirus vaccines: how well will they work where they are needed most? J Infect Dis (2009) 2.12

Detection of norovirus (GI, GII), Sapovirus and astrovirus in fecal samples using reverse transcription single-round multiplex PCR. J Virol Methods (2003) 2.08

Real-world impact of rotavirus vaccination. Pediatr Infect Dis J (2011) 1.89

Identification of Listeria species by microarray-based assay. J Clin Microbiol (2002) 1.87

United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction. Pediatr Infect Dis J (2011) 1.83

Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data. Pediatr Infect Dis J (2011) 1.63

Safety, immunogenicity, and protective efficacy of two doses of RIX4414 live attenuated human rotavirus vaccine in healthy infants. J Pediatr (Rio J) (2007) 1.62

Bovine kobuviruses from cattle with diarrhea. Emerg Infect Dis (2008) 1.61

First report from the Asian Rotavirus Surveillance Network. Emerg Infect Dis (2004) 1.60

Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics (2010) 1.59

Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States. Pediatrics (2008) 1.58

Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: insights for understanding the impact of rotavirus vaccination programs. Vaccine (2012) 1.57

The role of serum antibodies in the protection against rotavirus disease: an overview. Clin Infect Dis (2002) 1.53

Development of candidate rotavirus vaccines derived from neonatal strains in India. J Infect Dis (2005) 1.52

Multicenter, hospital-based surveillance of rotavirus disease and strains among indian children aged <5 years. J Infect Dis (2009) 1.49

Severe acute rotavirus gastroenteritis in children less than 5 years in southern Ghana: 2006-2011. Pediatr Infect Dis J (2014) 1.45

Novel porcine rotavirus of genotype P[27] shares new phylogenetic lineage with G2 porcine rotavirus strain. Virology (2007) 1.43

Whole genome sequence and phylogenetic analyses reveal human rotavirus G3P[3] strains Ro1845 and HCR3A are examples of direct virion transmission of canine/feline rotaviruses to humans. Virology (2008) 1.43

Changing distribution of norovirus genotypes and genetic analysis of recombinant GIIb among infants and children with diarrhea in Japan. J Med Virol (2006) 1.43

Incidence and risk factors of paediatric rotavirus diarrhoea in northern Ghana. Trop Med Int Health (2003) 1.42

Monitoring of poliovirus neutralizing antibodies in São Paulo State, Brazil. Trans R Soc Trop Med Hyg (2010) 1.42

Burden and epidemiology of rotavirus diarrhea in selected African countries: preliminary results from the African Rotavirus Surveillance Network. J Infect Dis (2010) 1.40

Human bocavirus infection in children with gastroenteritis, Brazil. Emerg Infect Dis (2007) 1.36

Secular variation in United States rotavirus disease rates and serotypes: implications for assessing the rotavirus vaccination program. Pediatr Infect Dis J (2009) 1.36

Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: A randomized, placebo-controlled trial in Latin American infants. Pediatr Infect Dis J (2005) 1.35

Global impact of rotavirus vaccines. Expert Rev Vaccines (2010) 1.34

Microarray analysis of evolution of RNA viruses: evidence of circulation of virulent highly divergent vaccine-derived polioviruses. Proc Natl Acad Sci U S A (2003) 1.33

Transient MR signal changes in the splenium of the corpus callosum in rotavirus encephalopathy: value of diffusion-weighted imaging. J Comput Assist Tomogr (2002) 1.32

Porcine kobuvirus in piglets, Thailand. Emerg Infect Dis (2009) 1.29

Diversity of rotavirus strains among children with acute diarrhea in China: 1998-2000 surveillance study. J Clin Microbiol (2002) 1.29

Rapid determination of viral RNA sequences in mosquitoes collected in the field. J Virol Methods (2007) 1.27

Astrovirus detection in sporadic cases of diarrhea among hospitalized and non-hospitalized children in Rio De Janeiro, Brazil, from 1998 to 2004. J Med Virol (2008) 1.27

Effectiveness of pentavalent rotavirus vaccine against severe disease. Pediatrics (2011) 1.26

Dengue virus type 4 phylogenetics in Brazil 2011: looking beyond the veil. PLoS Negl Trop Dis (2011) 1.26

New oligonucleotide primers for P-typing of rotavirus strains: Strategies for typing previously untypeable strains. J Clin Virol (2008) 1.23

Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011. Clin Infect Dis (2013) 1.23

Sibling transmission of vaccine-derived rotavirus (RotaTeq) associated with rotavirus gastroenteritis. Pediatrics (2010) 1.23

Detection, genetic characterization, and quantification of norovirus RNA from sera of children with gastroenteritis. J Clin Virol (2009) 1.23

Risk factors for protein-energy malnutrition in children under 5 years: study from Luangprabang province, Laos. Pediatr Int (2007) 1.22

Multipathogen oligonucleotide microarray for environmental and biodefense applications. Biosens Bioelectron (2004) 1.21

Microarray-based identification of thermophilic Campylobacter jejuni, C. coli, C. lari, and C. upsaliensis. J Clin Microbiol (2003) 1.21

Refractory pemphigus vulgaris associated with herpes infection: case report and review. Rev Inst Med Trop Sao Paulo (2011) 1.20

Prevalence of hepatitis virus types B through E and genotypic distribution of HBV and HCV in Ho Chi Minh City, Vietnam. Hepatol Res (2003) 1.20

Molecular epidemiology of rotavirus infection in Western Cameroon. J Trop Pediatr (2003) 1.19

A single-tube multiplex PCR for rapid detection in feces of 10 viruses causing diarrhea. J Virol Methods (2011) 1.18

Novel human adenovirus strain, Bangladesh. Emerg Infect Dis (2012) 1.17

Inactivated rotavirus vaccines: a priority for accelerated vaccine development. Vaccine (2008) 1.17

High prevalence of hepatitis B virus pre-s mutant in countries where it is endemic and its relationship with genotype and chronicity. J Clin Microbiol (2003) 1.16

Diversity of viruses associated with acute gastroenteritis in children hospitalized with diarrhea in Ho Chi Minh City, Vietnam. J Med Virol (2007) 1.15

Genetic diversity of noroviruses and sapoviruses in children hospitalized with acute gastroenteritis in Chiang Mai, Thailand. J Med Virol (2007) 1.15

Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belém, Brazil. Pediatr Infect Dis J (2011) 1.14

Inactivated rotavirus vaccine induces protective immunity in gnotobiotic piglets. Vaccine (2010) 1.14

Genotype C of hepatitis B virus can be classified into at least two subgroups. J Gen Virol (2004) 1.13

Epidemiological profile and burden of rotavirus diarrhea in Vietnam: 5 years of sentinel hospital surveillance, 1998-2003. J Infect Dis (2005) 1.13

Proteolytic processing of sapovirus ORF1 polyprotein. J Virol (2005) 1.13

The psychological effects of aromatherapy-massage in healthy postpartum mothers. J Midwifery Womens Health (2006) 1.13

Epidemiological features of rotavirus infection among hospitalized children with gastroenteristis in Ho Chi Minh City, Vietnam. J Med Virol (2003) 1.12

Outbreaks of adult gastroenteritis traced to a single genotype of rotavirus. J Infect Dis (2002) 1.11

Genetic heterogeneity, evolution, and recombination in noroviruses. J Med Virol (2007) 1.11

Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality. Expert Rev Vaccines (2012) 1.10

Human astrovirus, norovirus (GI, GII), and sapovirus infections in Pakistani children with diarrhea. J Med Virol (2004) 1.10

A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis. Pediatr Infect Dis J (2004) 1.10

The pathology of rotavirus-associated deaths, using new molecular diagnostics. Clin Infect Dis (2003) 1.10

Molecular characterization of a rare G3P[3] human rotavirus reassortant strain reveals evidence for multiple human-animal interspecies transmissions. J Med Virol (2006) 1.09

Detection of rare G3P[19] porcine rotavirus strains in Chiang Mai, Thailand, provides evidence for origin of the VP4 genes of Mc323 and Mc345 human rotaviruses. J Clin Microbiol (2006) 1.09

Feeding practice of infants and their correlates in urban areas of Beijing, China. Pediatr Int (2003) 1.09

Innate immune defense of the sponge Suberites domuncula against bacteria involves a MyD88-dependent signaling pathway. Induction of a perforin-like molecule. J Biol Chem (2005) 1.08

Update on Rotarix: an oral human rotavirus vaccine. Expert Rev Vaccines (2009) 1.07

Update on rotavirus vaccines. Pediatr Infect Dis J (2005) 1.06

Rotavirus serotype G9 strains belonging to VP7 gene phylogenetic sequence lineage 1 may be more suitable for serotype G9 vaccine candidates than those belonging to lineage 2 or 3. J Virol (2004) 1.06

Emergence and disappearance of an immune molecule, an antimicrobial lectin, in basal metazoa. A tachylectin-related protein in the sponge Suberites domuncula. J Biol Chem (2003) 1.06

Detection and discrimination of orthopoxviruses using microarrays of immobilized oligonucleotides. J Virol Methods (2003) 1.06

Safety and immunogenicity of two live attenuated human rotavirus vaccine candidates, 116E and I321, in infants: results of a randomised controlled trial. Vaccine (2006) 1.05

Rotavirus disease and its prevention. Curr Opin Gastroenterol (2005) 1.05

Detection and genetic characterization of norovirus strains circulating among infants and children with acute gastroenteritis in Japan during 2004-2005. Clin Lab (2006) 1.05

Factors determining prenatal HIV testing for prevention of mother to child transmission in Dar Es Salaam, Tanzania. Pediatr Int (2007) 1.05

Rotavirus infection alters peripheral T-cell homeostasis in children with acute diarrhea. J Virol (2007) 1.05

Characterization of a broadly reactive monoclonal antibody against norovirus genogroups I and II: recognition of a novel conformational epitope. J Virol (2007) 1.04

Genetic variations in the gB, UL144 and UL149 genes of human cytomegalovirus strains collected from congenitally and postnatally infected Japanese children. Arch Virol (2008) 1.04

Reassortant group A rotavirus from straw-colored fruit bat (Eidolon helvum). Emerg Infect Dis (2010) 1.04

Street children in Pakistan: a situational analysis of social conditions and nutritional status. Soc Sci Med (2004) 1.04

Genomic characterization of a novel human adenovirus type 31 recombinant in the hexon gene. J Gen Virol (2011) 1.04

Development of RT-multiplex PCR assay for detection of adenovirus and group A and C rotaviruses in diarrheal fecal specimens from children in China. Kansenshogaku Zasshi (2004) 1.03

Application of cell culture enrichment for improving the sensitivity of mycoplasma detection methods based on nucleic acid amplification technology (NAT). Appl Microbiol Biotechnol (2007) 1.03

Viral gastroenteritis in Mongolian infants. Emerg Infect Dis (2005) 1.03

Co-expression and functional interaction of silicatein with galectin: matrix-guided formation of siliceous spicules in the marine demosponge Suberites domuncula. J Biol Chem (2006) 1.03

Molecular epidemiology of adenovirus infection among infants and children with acute gastroenteritis in Dhaka City, Bangladesh. Infect Genet Evol (2009) 1.03

Accurate mapping of mutations of pyrazinamide-resistant Mycobacterium tuberculosis strains with a scanning-frame oligonucleotide microarray. Diagn Microbiol Infect Dis (2004) 1.02

Novel respiratory virus infections in children, Brazil. Emerg Infect Dis (2009) 1.02